We are committed to making the full therapeutic potential of cannabinoid pharmaceuticals available to Australian healthcare professionals and patients.
Our medical team leads the world in defining the physiological pathways of the endocannabinoid system. Our research goals identify conditions where the therapeutic benefits are most significant.
THE GOLD STANDARD OF MEDICAL CANNABIS
Medropharm's products are tested for various containments including metals, salmonella, and E.coli. The purity of our cannabis products is paramount, and other microorganisms like S. aureus, yeast, and mould are kept well below food-safe levels. These standards comply with worldwide pharmacopeia limits for natural health products.